Recently, Kim et al. (2019) established a gastrointestinal α-synuclein-injected PD mouse model characterized by PD with both motor and non-motor symptoms, suggesting it as a new model with α-synucleinopathies, one of the main features of PD. Here, SNCA is linked to synucleinopathy.